期刊文献+

不同风险振动阈值的2型糖尿病患者临床特征 被引量:2

Clinical characteristics of type 2 diabetes mellitus with different risk degrees of vibration perception threshold
原文传递
导出
摘要 目的探讨不同振动阈值(VPT)危险分度的T2DM患者临床特点。方法采用Bio-thesiometer感觉定量检查仪测定T2DM患者下肢的VPT。根据VPT的结果将患者分为低度风险组(0~15V)、中度风险组(16~25V)和重度风险组(>25V),并探讨不同VPT风险组的临床特点和构成比,以及不同VPT危险分度和病程的关系。结果 VPT中、重度风险组的年龄、HbA1c和病程高于低度风险组(P<0.05);VPT中度受损占26.2%,重度受损占9.2%;中、重度风险组存在明显血脂代谢紊乱;胰岛β细胞功能指数(HOMA-β)中重度风险组明显低于低风险组(P<0.05和P<0.01)。结论 T2DM患者VPT受损与年龄、病程、HbA1c、HOMA-β和血脂密切相关。 Objective To explore the clinical characteristics of T2DM patients with different risk degree of vibration threshold(VPT) values.Methods A Bio-thesiometer was adopted to measure the VPT of lower limbs of the T2DM patients.According to the result of measurements,the patients were divided into three groups: low risk group(0~15V),moderate risk group(16~25V),and high risk group(25V).The clinical characteristics of patients with different risk degrees of VPT and the relationship between the different dangerous degrees and diabetes course were discussed.Results The age,HbA1c,and diabetes course of the patients were higher in the moderate and severe risk groups than in the low risk group.The moderate impaired VPT occupied 26.2% and the severe impaired VPT occupied 9.2%.Obvious lipid metabolic disorders existed in the moderate and severe risk groups.HOMA-β in the moderate and severe risk groups was significantly lower than in the low risk group(P0.05,P0.01). Conclusion The VPT impairment of T2DM patients was related with the age,HbA1c,HOMA-β,duration,and serum lipids.
作者 王全胜 郁敏
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2013年第2期149-151,共3页 Chinese Journal of Diabetes
关键词 振动阈值 糖尿病 2型 糖尿病周围神经病变 Vibration perception threshold(VPT) Diabetes mellitus type 2 Diabetic neuropathy(DNP)
  • 相关文献

参考文献6

  • 1Czura CJ, Tracey KJ. Autonomic neural regulation of immuni-ty. J Intern Med, 2005? 257: 156-166.
  • 2贾晓凡,张木勋,郭伟,袁刚,金霞.定量感觉检查对糖尿病周围神经病变的诊断价值[J].中华物理医学与康复杂志,2005,27(10):610-613. 被引量:21
  • 3Garrow AP, Boulton AJ. Vibration perception threshold-a val-uable assessment of neural dysfunction in people with diabetes.Diabetes Metab Res Rev, 2006, 22:411-419.
  • 4Martin CL, Waberski BH, Pop-Busui R, et al. DCCT/EDICResearch Group. Vibration perception threshold as a measureof distal symmetrical peripheral neuropathy in type 1 diabetes:results from the DCCT/EDIC study. Diabetes Care, 2010 Dec;5 Freeman R. Not all neuropathy in diabetes is of diabetic eti-ology: differential diagnosis of diabetic neuropathy. Curr DizbReo, 2009,9: 423-441.
  • 5Dyck PJ, Davies JL, Wilson DM, et al. Risk factors for sever-ity of diabetic polyneuropathy: intensive longitudinal assess-ment of the rochester diabetic neuropathy study cohort. EHabe-tes Care, 1999,22: 1479-1486.
  • 6Kolia VK, Madhavi G. interferon gamma and interleukin 10gene polymorphisms with peripheral neuropathy in South Indi-an patients with type 2 diabetes. Gytokine,2009, 47: 173-177.

二级参考文献12

  • 1Mueller MJ.Identifying patients with diabetes mellitus who are at risk for lower extremity complications:use of Semmes Weinstein monofilaments.Phys Ther,1996,76:68-71.
  • 2Young MJ,Breddy L,Veves A,et al.The prediction of diabetic neuropathic foot ulceration using vibratory perception thresholds.Diabetes Care,1994,17:557-560.
  • 3American Diabetes Association American Academy of Neurology. Consensus statement:report and recommendations of the San Antonio confe-rence on diabetic neuropathy.Diabetes Care,1988,11:592-597.
  • 4Meijer JW,Smit AJ,Sonderent EV,et al.Symptom scoring systems to diagnose distal polyneuropathy in diabetes:the diabetic neuropathy symptom score.Diabet Med,2002,19:962-965.
  • 5Jensen TS,Bach FW,Kastrup J,et al.Vibratory and thermal thresholds in diabetics with and without clinical neuropathy.Acta Neurol Scand,1991,84:326-333.
  • 6Sasaki H,Nanjo K,Yamada M,et al.Diabetic neuropathy as a heterogeneous syndrome:multivariate analysis of clinical and neurological findings.Diabetes Res Clin Pract,1988,4:215-222.
  • 7Gelber DA,Pfeifer MA,Broadstone VL,et al.Components of variance for vibratory and thermal threshold testing in normal and diabetic subjects.J Diabetes Complications,1995,9:170-176.
  • 8Hodge AM,Dowse GK,Zimmet PZ,et al.Factors associated with impaired vibration perception in Mauritians with normal and abnormal glucose tolerance.J Diabetes Complications,1995,9:149-157.
  • 9Wiles PG,Pearce SM,Rice PJ,et al.Vibration perception threshold:influence of age,height,sex,and smoking,and calculation of accurate centile values.Diabet Med,1991,8:157-161.
  • 10Rahman M,Griffin SJ,Rathmann W,et al.How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-based comparison of four measures.Diabet Med,2003,20:368-374.

共引文献20

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部